Finance

Lists
Why is INKT down 3.47%?
Dive Deeper
INKT:NASDAQ
Mink Therapeutics Inc
$11.42
-3.47%
(-0.41) 1D
Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INKT...
Open
$11.63
High
$11.63
Low
$11.32
Mkt. cap
58.28M
Avg. vol.
18.02K
Volume
13.81K
52-wk high
$16.93
52-wk low
$8.48
EPS
-$2.40
Beta
0.47
Shares outstanding
5.10M
No. of employees
15
Open
$11.63
High
$11.63
Low
$11.32
Mkt. cap
58.28M
Avg. vol.
18.02K
Volume
13.81K
52-wk high
$16.93
52-wk low
$8.48
EPS
-$2.40
Beta
0.47
Shares outstanding
5.10M
No. of employees
15
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
14 hours ago
Understanding Momentum Shifts in (INKT)
About Mink Therapeutics Inc
CEO-
Employees15
Founded2017
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to INKT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INKT in the last 3 months
Highest
Current $11.42
$35.00 (+206.48%)
Average
$35.00 (+206.48%)
Lowest
$35.00 (+206.48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$35.00
+206.5%
08/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.14M
1.51M
1.20M
1.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.85M
1.76M
1.68M
1.33M
Operating expense
3.18M
2.71M
2.88M
3.22M
Total operating expenses
3.18M
2.71M
2.88M
3.22M
Operating income
-3.18M
-2.71M
-2.88M
-3.22M
Other non operating income
240.73K
-7.87K
58.58K
-
EBT including unusual items
-2.89M
-2.60M
-2.74M
-3.13M
EBT excluding unusual items
-2.89M
-2.60M
-2.74M
-3.13M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
193.92K
-571.10K
-
-
Net income
-2.89M
-2.60M
-2.74M
-3.13M
Net profit margin
-
-
-
-
Earnings per share
-0.65
-0.56
-0.57
-0.62
Interest and investment income
55.15K
111.23K
80.83K
72.88K
Interest expense
-
-
-
-
Net interest expenses
55.15K
111.23K
80.83K
72.88K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.14M
-2.67M
-2.85M
-3.18M
Gain or loss from assets sale
2.19K
509.00
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps